Particulars (Rupees in Crores.) | Sept-2024 | Mar-2024 | Sept-2023 | Mar-2023 | Sept-2022 |
---|---|---|---|---|---|
Gross Sales | 1,475.57 | 1,337.49 | 1,419.44 | 1,229.62 | 1,256.4 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,475.57 | 1,337.49 | 1,419.44 | 1,229.62 | 1,256.4 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 26.25 | 23.56 | 30.17 | 20.96 | 25.6 |
Total Income | 1,501.82 | 1,361.05 | 1,449.61 | 1,250.58 | 1,282 |
Total Expenditure | 1,203.67 | 1,110.48 | 1,166.65 | 1,054 | 1,116.15 |
PBIDT | 298.15 | 250.57 | 282.96 | 196.58 | 165.85 |
Interest | 2.79 | 2.45 | 2.28 | 6.33 | 6.76 |
PBDT | 295.36 | 248.12 | 280.68 | 190.25 | 159.09 |
Depreciation | 27.3 | 25.69 | 24.27 | 24.06 | 26.06 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 47.02 | 38.62 | 45.34 | 29.32 | 24.73 |
Deferred Tax | 14.33 | 14.74 | 10.84 | 10.22 | -4.78 |
Reported Profit After Tax | 206.71 | 169.07 | 200.23 | 126.65 | 113.08 |
Minority Interest After NP | -0.01 | 0.02 | -0.17 | 0 | -0.01 |
Net Profit after Minority Interest | 206.72 | 169.05 | 200.4 | 126.65 | 113.09 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 5.72 |
Adjusted Profit After Extra-ordinary item | 206.72 | 169.05 | 200.4 | 126.65 | 107.37 |
EPS (Unit Curr.) | 5.63 | 4.6 | 5.46 | 3.45 | 3.08 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 36.72 | 36.72 | 36.72 | 36.72 | 36.72 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 20.2 | 18.73 | 19.93 | 15.98 | 13.2 |
PBDTM(%) | - | - | - | - | - |
PATM(%) | 14 | 12.64 | 14.1 | 10.29 | 9 |
The sale was approved by the Board of Directors at a meeting held on March 25, 2025. Post sale, JKBL ceases to be a subsidiary of Jyothy Labs.
Operating EBITDA grew by 2.3% YoY, reaching ₹138.5 Crore, up from ₹135.4 Crore in the previous year’s Q2.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.